Literature DB >> 16393962

Early preplasma cells define a tolerance checkpoint for autoreactive B cells.

Donna A Culton1, Brian P O'Conner, Kara L Conway, Ramiro Diz, Jennifer Rutan, Barbara J Vilen, Stephen H Clarke.   

Abstract

Ab-secreting plasma cells (PCs) are the effectors of humoral immunity. In this study, we describe regulation of autoreactive B cells specific for the ribonucleoprotein Smith (Sm) at an early pre-PC stage. These cells are defined by the expression of the PC marker CD138 and normal levels of CD19 and B220. They are present at a high frequency in normal mouse spleen and bone marrow, are Ag dependent, and are located predominantly along the T cell-B cell border and near bridging channels. Anti-Sm pre-PCs also occur at a high frequency in nonautoimmune mice and show additional phenotypic characteristics of PC differentiation. However, while some of these pre-PCs are Ab-secreting cells, those specific for Sm are not, indicating regulation. Consistent with this, anti-Sm pre-PCs have a higher turnover rate and higher frequency of cell death than those that do not bind Sm. Regulation of anti-Sm pre-PCs occurs upstream of the transcriptional repressor, B lymphocyte-induced maturation protein-1, expression. Regulation at this stage is overcome in autoimmune MRL/lpr mice and is accompanied by an altered B lymphocyte stimulator receptor profile. These data reveal a new B cell tolerance checkpoint that is overcome in autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16393962      PMCID: PMC3709567          DOI: 10.4049/jimmunol.176.2.790

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens.

Authors:  F Martin; A M Oliver; J F Kearney
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

2.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.

Authors:  J A Gross; J Johnston; S Mudri; R Enselman; S R Dillon; K Madden; W Xu; J Parrish-Novak; D Foster; C Lofton-Day; M Moore; A Littau; A Grossman; H Haugen; K Foley; H Blumberg; K Harrison; W Kindsvogel; C H Clegg
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

3.  Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds.

Authors:  Y Qian; C Santiago; M Borrero; T F Tedder; S H Clarke
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

4.  Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: altered differentiation and an accelerated response.

Authors:  S Santulli-Marotto; Y Qian; S Ferguson; S H Clarke
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

5.  BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.

Authors:  A L Shaffer; X Yu; Y He; J Boldrick; E P Chan; L M Staudt
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

6.  Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes.

Authors:  N Wehrli; D F Legler; D Finke; K M Toellner; P Loetscher; M Baggiolini; I C MacLennan; H Acha-Orbea
Journal:  Eur J Immunol       Date:  2001-02       Impact factor: 5.532

7.  Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo.

Authors:  C Angelin-Duclos; G Cattoretti; K I Lin; K Calame
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

8.  A coordinated change in chemokine responsiveness guides plasma cell movements.

Authors:  D C Hargreaves; P L Hyman; T T Lu; V N Ngo; A Bidgol; G Suzuki; Y R Zou; D R Littman; J G Cyster
Journal:  J Exp Med       Date:  2001-07-02       Impact factor: 14.307

Review 9.  Revising B cell receptors.

Authors:  D Nemazee; M Weigert
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

10.  Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6.

Authors:  R Reljic; S D Wagner; L J Peakman; D T Fearon
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

View more
  43 in total

1.  Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells.

Authors:  Ming You; Guanjun Dong; Fanlin Li; Feiya Ma; Jing Ren; Yujun Xu; Huimin Yue; Ruijing Tang; Deshan Ren; Yayi Hou
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

Review 2.  Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate.

Authors:  Karsten Sauer; Michael P Cooke
Journal:  Nat Rev Immunol       Date:  2010-04       Impact factor: 53.106

Review 3.  BAFF and selection of autoreactive B cells.

Authors:  Zheng Liu; Anne Davidson
Journal:  Trends Immunol       Date:  2011-07-13       Impact factor: 16.687

Review 4.  Understanding B-cell tolerance through the use of immunoglobulin transgenic models.

Authors:  Kirthi Raman Kumar; Chandra Mohan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

5.  T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells.

Authors:  Robin A Herlands; Sean R Christensen; Rebecca A Sweet; Uri Hershberg; Mark J Shlomchik
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

6.  Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.

Authors:  Chuancang Jiang; Ming-Lang Zhao; Richard M Scearce; Marilyn Diaz
Journal:  Arthritis Rheum       Date:  2011-04

7.  Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6.

Authors:  Michelle A Kilmon; Nikki J Wagner; Alaina L Garland; Li Lin; Katja Aviszus; Lawrence J Wysocki; Barbara J Vilen
Journal:  Blood       Date:  2007-09-01       Impact factor: 22.113

8.  Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance.

Authors:  Laurent Verkoczy; Marilyn Diaz; T Matt Holl; Ying-Bin Ouyang; Hilary Bouton-Verville; S Munir Alam; Hua-Xin Liao; Garnett Kelsoe; Barton F Haynes
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

Review 9.  B cells and immunological tolerance.

Authors:  Nataly Manjarrez-Orduño; Tâm D Quách; Iñaki Sanz
Journal:  J Invest Dermatol       Date:  2009-02       Impact factor: 8.551

10.  Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity.

Authors:  Wenzhong Guo; Diana Smith; Katja Aviszus; Thiago Detanico; Ryan A Heiser; Lawrence J Wysocki
Journal:  J Exp Med       Date:  2010-08-30       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.